N
EW YORK--Pfizer has agreed to pay annual subscription fees of an undisclosed amount in order to gain access to Gene Logic’s GeneExpress database for predictive toxicology applications. Gene Logic claimed that the database is the world’s most comprehensive survey of gene expression data from human and experimental animal tissue. Other subscribers include Aventis, Merck, PE Biosystems, and SmithKline Beecham.
Comprising the database are data on normal and diseased human tissue samples for target discovery and validation; human and experimental animal tissues treated with known toxic compounds for predictive toxicology assessment; and samples treated with known therapeutic compounds for optimization of testing and refining current drug candidates.
